Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Osteopore Ltd. ( (AU:OSX) ) has issued an announcement.
Osteopore Limited reported a revenue of AUD 812K for the third quarter of 2025, marking a 7% year-over-year growth. The company also achieved a significant milestone by securing market approval in Switzerland under the EU MDR clearance for its custom orthopedic and cranial implants, potentially enhancing its market presence in Europe.
More about Osteopore Ltd.
Osteopore Limited is a manufacturer in the medical industry, specializing in regenerative implants that facilitate natural tissue regeneration. The company focuses on producing custom orthopedic and cranial implants.
Average Trading Volume: 2,249,635
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$2.61M
See more data about OSX stock on TipRanks’ Stock Analysis page.